- Tucscon, Ariz.-based Ventana developed the Ventana PD-L1 Assay to gauge a patient’s expected responsiveness to immunotherapy treatments.
- Baserl, Switzerland-based Roche’s cobas MPX test detects HIV-1 and HIV-2, hepatitis B virus and hepatitis C virus in blood donations.
- Norcross, Ga.-based Immucor’s PreciseType HEA test to screen blood donations for signs of sickle cell disease.
- Kenilworth, N.J.-based Merck’s cancer drug Keytruda can now be used as an initial treatment for patients with lung cancer.
- Dublin-based Medtronic developed the CoreValve Evolut R 34 mm valve, a transcatheter aortic valve replacement system.
More articles on supply chain:
FDA approves Medtronic’s larger aortic valve replacement system
Kits for care: How global sourcing helped Northside Hospital boost patient comfort
EpiPen price hikes cost DOD millions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.